Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» HIV
HIV
Look at our new launches, GSK urges, as its respiratory woes steal the limelight
Fierce Pharma
Wed, 04/25/18 - 10:38 pm
GSK
earnings
HIV
Shingrix
Gene editing shows promise in combating HIV reservoirs
Fierce Biotech
Sat, 04/21/18 - 12:47 pm
gene editing
HIV
Gilead: Did Biktarvy Kill The Sell Thesis?
Seeking Alpha
Tue, 03/27/18 - 09:54 am
Gilead Sciences
Biktarvy
HIV
Kite Pharma
3 Blockbuster Drug Launches to Watch In 2018
Motley Fool
Mon, 03/26/18 - 10:45 am
drug launches
Gilead Sciences
HIV
Biktarvy
Alnylam
Sanofi
Patisiran
Epidiolex
GW Pharma
GSK's two-drug HIV regimen wins European panel approval
Reuters
Sat, 03/24/18 - 09:05 am
GSK
HIV
Europe
CHMP
Juluca
Gilead Sciences' $14 Billion-Per-Year Threat
Motley Fool
Sun, 03/18/18 - 11:26 am
Gilead Sciences
GS-9620
GS-9722
HIV
Is Gilead Sciences Trying to Put Itself Out of Business?
Motley Fool
Wed, 03/14/18 - 09:31 pm
Gilead Sciences
hepatitis C
HIV
GS-9620
PGT121
Searching for HIV cure, Gilead’s new ‘shock and kill’ combo swats back lethal virus in monkeys
Endpoints
Tue, 03/6/18 - 09:38 am
HIV
Gilead Sciences
R&D
How Huge Is the Latest HIV Drug Approval for Gilead Sciences?
Motley Fool
Mon, 02/12/18 - 09:16 am
Gilead Sciences
HIV
FDA
Biktarvy
No more Mr Nice Guy: GlaxoSmithKline is coming out of its corner swinging
Endpoints
Thu, 02/8/18 - 11:18 am
GSK
R&D
Pharma CEOs
Emma Walmsley
Advair
Novartis
Sandoz
Gilead Sciences
HIV
A new pill to treat HIV just got approved — and it could shake up a $22 billion market
Business Insider
Thu, 02/8/18 - 09:30 am
HIV
Gilead Sciences
FDA
Bictegravir/emtricitabine/tenofovir alafenamide
Ready to take on Glaxo, Gilead's combo HIV med Biktarvy wins $6B FDA nod
Fierce Pharma
Wed, 02/7/18 - 10:32 pm
GSK
Gilead Sciences
HIV
FDA
Biktarvy
Aetna to pay $17 million over mailing that revealed HIV meds
Stat
Wed, 01/17/18 - 09:50 pm
Aetna
HIV
patients
privacy
5 Ways Gilead Sciences Plans to Return to Growth
Motley Fool
Tue, 01/9/18 - 10:55 pm
Gilead Sciences
HIV
liver disease
cell therapy
inflammation
M&A
Teva rolls out exclusive generic of Gilead's Viread at the end of an awful week
Fierce Pharma
Fri, 12/15/17 - 11:40 pm
Teva Pharmaceutical
Gilead Sciences
Viread
hepatitis B
HIV
antivirals
Why Gilead Could Have 'Greatest' Ever In HIV Drug Launches
Investors Business Daily
Thu, 12/7/17 - 09:16 am
Gilead Sciences
drug launches
HIV
bictegravir
J&J-led coalition launches a landmark efficacy study for an HIV mosaic vaccine
Endpoints
Thu, 11/30/17 - 09:46 am
JNJ
HIV
vaccines
R&D
mosaic vaccine
Imbokodo
HVTN 705/HPX2008
Fresh off its Juluca approval, GlaxoSmithKline beefs up trials of long-acting HIV duo
Fierce Pharma
Tue, 11/28/17 - 09:05 pm
GSK
cabotegravir
HIV
Endurant
ViiV
JNJ
Janssen
J&J & Glaxo's Jucala Approval Puts Spotlight on HIV Space
Yahoo/Zacks.com
Sat, 11/25/17 - 12:39 pm
JNJ
GSK
Jucala
HIV
With billions riding on their success, GSK bags quick OK for its two-drug HIV combo Juluca
Endpoints
Tue, 11/21/17 - 10:47 pm
GSK
HIV
Juluca
ViiV
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »